Kingfa Science net profit up 111% in Q1FY27 to ₹802 crore
Kingfa Science & Technology (India) Ltd posted strong Q1FY27 results with net profit jumping 111% YoY to ₹802 crore on the back of 49% revenue growth to ₹6,886 crore. EBITDA margin expanded to 16.12%, reflecting improved operating efficiency. Domestic sales drove the top-line growth, constituting 92% of revenue.

*this image is generated using AI for illustrative purposes only.
Kingfa Science & Technology reported a substantial improvement in profitability for the first quarter of FY27, with net profit rising to ₹802 crore compared to ₹380 crore in the corresponding period last year. The company’s top-line growth was equally robust, as revenue climbed 49% year-on-year to ₹6,886 crore from ₹4,619 crore. The results were filed with stock exchanges on August 14, 2026.
Operating efficiency also strengthened during the period. EBITDA increased to ₹1,100 crore from ₹581 million, reflecting an expansion in operating leverage. The EBITDA margin widened to 16.12% from 12.58% in the prior year, indicating better cost management relative to sales volume.
Financial Highlights
| Metric: | Q1 FY27: | Q1 FY26: | Change: |
|---|---|---|---|
| Revenue: | ₹6,886 crore | ₹4,619 crore | +49.1% |
| EBITDA: | ₹1,100 crore | ₹581 million | +89.7% |
| EBITDA Margin: | 16.12% | 12.58% | +354 bps |
| Net Profit: | ₹802 crore | ₹380 crore | +111.1% |
Revenue Breakdown
Domestic sales remained the primary growth driver, accounting for 92% of total revenue in Q1FY27. Domestic sales stood at ₹6,349 crore, up significantly from ₹4,251 crore in Q1FY26. Export sales contributed 8% of the total, rising to ₹536 crore from ₹368 crore in the same period last year.
The company also reported a sequential increase in revenue. Total revenue from operations in Q1FY27 was ₹6,886 crore, compared to ₹5,785 crore in Q4FY26, representing a 19% quarter-on-quarter increase.
What the Numbers Show
The divergence between revenue growth (49%) and net profit growth (111%) highlights significant operating leverage. With EBITDA growing at nearly 90%, the company effectively translated higher sales into disproportionately higher earnings, driven by the expansion in EBITDA margin from 12.58% to 16.12%. This suggests that fixed costs were absorbed more efficiently as volumes scaled.
Earnings per share (basic) stood at ₹59.19 in Q1FY27, compared to ₹43.65 in Q4FY26. The total comprehensive income for the period was ₹803 crore.
Historical Stock Returns for Kingfa Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.63% | +9.84% | +14.72% | +36.38% | +62.81% | +383.59% |
Can Kingfa sustain the 16.12% EBITDA margin expansion in Q2 FY27, or is this a one-off benefit from fixed cost absorption?
How will the company's heavy reliance on domestic sales (92%) impact its resilience against potential regional economic slowdowns compared to its export growth?
What specific strategic initiatives or product mix changes drove the 49% revenue surge, and are these growth drivers scalable over the full fiscal year?


































